Cervical RadiculopathyNCT07289607
Effect of TECAR on Cervical Radiculopathy
A study testing TECAR therapy in people with Cervical Radiculopathy, run by Delta University for Science and Technology at 1 site in Egypt.
Trial summary
Cervical radiculopathy is characterized by pain, sensory disturbances, and impaired neuromuscular control due to nerve root compression. Proprioception dysfunction is often an overlooked component of this condition and can affect balance, posture, and motor control. Read more about this study
- Who is it for?
- Ages 30 to 45 years
- Conditions the study is for
- Cervical Radiculopathy
- What is being tested?
- TECAR therapy
- Type of treatment
- Medical device
- Could I receive a placebo?
- Yes, some participants may receive a placebo
- How many people
- 80 participants
- Where
- 1 siteEgypt
- Study dates
- 1 Jan 2026to 5 Apr 2026
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 30 to 45 years
- All sexes
- No healthy volunteers
- Adult
Who may be able to join
- • Diagnosed cervical radiculopathy confirmed by clinical and radiological findings
- Age 30-40 years
- Pain duration > 4 weeks
Who cannot join
- • Cervical fracture or surgery
- Vestibular disorders
- Rheumatologic or neurological diseases
- Cognitive impairment or pregnancy
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
Egypt1 site
Private Clinic
Al Mansurah, 35511
ibrahim abu ella, 01008442281, ibrahimneuron@gmail.com
About this study
Official title: Effect of TECAR Therapy on Proprioception Function in Patients With Cervical Radiculopathy
Cervical radiculopathy is characterized by pain, sensory disturbances, and impaired neuromuscular control due to nerve root compression. Proprioception dysfunction is often an overlooked component of this condition and can affect balance, posture, and motor control.
TECAR (Transfer of Energy Capacitive and Resistive) therapy is a form of deep heat electrotherapy known to improve tissue perfusion and neuromuscular function. Although TECAR is widely used for pain relief and mobility, its role in improving proprioception remains under-investigated, especially in cervical conditions. This study aims to bridge this gap by assessing proprioceptive outcomes in patients with cervical radiculopathy receiving TECAR therapy.
Read the detailed description
- Design: Randomized controlled trial.
- Groups:
- Control group: Receives standard physiotherapy (e.g., cervical traction, exercises).
- Experimental group: Receives TECAR therapy in addition to standard physiotherapy.
- Duration: 3 sessions per week for 4 weeks.
- Outcome Measures: Joint position sense (JPS) using cervical repositioning tests, pain (VAS), functional disability (NDI).
- Assessment Times: Baseline and after 4 weeks.
- Conditions
- Cervical Radiculopathy
- Being tested
- TECAR therapy, Sham TECAR therapy
- Keywords
- TECAR , radiculopathy , Proprioception
- Medical subject headings
- Radiculopathy
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
TECAR therapyDevice
TECAR Therapy A form of radiofrequency-based deep thermotherapy that delivers energy into tissues using frequencies between 300 kHz and 1.2 MHz.
It heats from the inside out, giving deeper and more controlled thermal effects than superficial heat modalities.
Sham TECAR therapyDevice
TECAR Therapy a form of radiofrequency-based deep thermotherapy that delivers energy into tissues using frequencies between 300 kHz and 1.2 MHz.
It heats from the inside out, giving deeper and more controlled thermal effects than superficial heat modalities.
| Study group | Role | What they receive |
|---|---|---|
| study group | Active comparator | Receives TECAR therapy in addition to standard physiotherapy. Receives: Device: TECAR therapy |
| Control group | Sham comparator | Receives sham TECAR Receives: Device: Sham TECAR therapy |
What is being measured
The primary outcome is the main question the study is designed to answer.
proprioception function
assessment of proprioception functions via CROM
Measured: Baseline
Cervical ROM
ROM assessment via CROM
Measured: Baseline
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted17 Dec 2025
- Study start1 Jan 2026 (estimated)
- Primary completion5 Mar 2026 (estimated)
- Study completion5 Apr 2026 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (1)Papers the sponsor has linked to this study.
- Other trials for Cervical RadiculopathyStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind
- Who is masked
- Participant
- Enrolment
- 80 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Delta University for Science and Technology
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Ibrahim Ahmed Ibrahim Abu Ella, Delta University for Science and Technology
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07289607
- Sponsor's protocol ID
- P.T.REC/012/005936
- Status last verified
- Dec 2025
- First submitted
- 4 Dec 2025
- Last updated
- 18 Dec 2025
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No: CONFIDENTIALITY OF THE RESEARCH
Publications
Bameri A, Yassin M, Salehi R, Mansour Sohani S. The Effects of Manual Therapy with TECAR Therapy, on Pain, Disability and Range of Motion in Women with Non-specific Chronic Neck Pain. Med J Islam Repub Iran. 2024 Sep 17;38:107. doi: 10.47176/mjiri.38.107. eCollection 2024.
PubMed 39781327
Study at a glance
From the registry record, last updated by the sponsor on 18 Dec 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Effect of TECAR Therapy on Proprioception Function in Patients With Cervical Radiculopathy
- ClinicalTrials.gov ID
- NCT07289607
- Acronym / sponsor ID
- P.T.REC/012/005936
- Conditions
- Cervical Radiculopathy
- Keywords
- TECAR , radiculopathy , Proprioception
- Study type
- Interventional
- Recruitment status
- Not yet recruiting
- Enrolment
- 80 participants (estimated)
- Lead sponsor
- Delta University for Science and TechnologyUniversity, hospital or other
- Study start
- 1 Jan 2026 (estimated)
- Primary completion
- 5 Mar 2026 (estimated)
- Study completion
- 5 Apr 2026 (estimated)
- First posted
- 17 Dec 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Cervical radiculopathy is characterized by pain, sensory disturbances, and impaired neuromuscular control due to nerve root compression. Proprioception dysfunction is often an overlooked component of this condition and can affect balance, posture, and motor control.
TECAR (Transfer of Energy Capacitive and Resistive) therapy is a form of deep heat electrotherapy known to improve tissue perfusion and neuromuscular function. Although TECAR is widely used for pain relief and mobility, its role in improving proprioception remains under-investigated, especially in cervical conditions. This study aims to bridge this gap by assessing proprioceptive outcomes in patients with cervical radiculopathy receiving TECAR therapy.
Detailed description
- Design: Randomized controlled trial.
- Groups:
- Control group: Receives standard physiotherapy (e.g., cervical traction, exercises).
- Experimental group: Receives TECAR therapy in addition to standard physiotherapy.
- Duration: 3 sessions per week for 4 weeks.
- Outcome Measures: Joint position sense (JPS) using cervical repositioning tests, pain (VAS), functional disability (NDI).
- Assessment Times: Baseline and after 4 weeks.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (participant)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| study group | Active comparator | Device: TECAR therapyReceives TECAR therapy in addition to standard physiotherapy. |
| Control group | Sham comparator | Device: Sham TECAR therapyReceives sham TECAR |
Who may qualify
- Ages
- 30 to 45 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult
Key inclusion criteria (3 listed)
- • Diagnosed cervical radiculopathy confirmed by clinical and radiological findings
Key exclusion criteria (4 listed)
- • Cervical fracture or surgery
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| TECAR therapyTECAR Therapy A form of radiofrequency-based deep thermotherapy that delivers energy into tissues using frequencies between 300 kHz and 1.2 MHz. It heats from the inside out, giving deeper and more controlled thermal effects than superficial heat modalities. | Device | study group |
| Sham TECAR therapyTECAR Therapy a form of radiofrequency-based deep thermotherapy that delivers energy into tissues using frequencies between 300 kHz and 1.2 MHz. It heats from the inside out, giving deeper and more controlled thermal effects than superficial heat modalities. | Device | Control group |
Primary outcome
proprioception function
Time frame: Baseline
assessment of proprioception functions via CROM
Cervical ROM
Time frame: Baseline
ROM assessment via CROM
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 18 Dec 2025.
- Background: PubMed 39781327Bameri A, Yassin M, Salehi R, Mansour Sohani S. The Effects of Manual Therapy with TECAR Therapy, on Pain, Disability and Range of Motion in Women with Non-specific Chronic Neck Pain. Med J Islam Repub Iran. 2024 Sep 17;38:107. doi: 10.47176/mjiri.38.107. eCollection 2024.
- Individual participant dataSharing planned: No. CONFIDENTIALITY OF THE RESEARCH
Related trials for Cervical Radiculopathy
Recruiting
Ultrasound-Guided Electrical Dry Needling for Chronic Cervical Radiculopathy
Cervical Radiculopathy
Not yet recruitingObservational study
Correlation Between Forward Head Posture and Executive Functions in Cervical Radiculopathy
Cervical Radiculopathy, Forward Head Posture
Recruiting
Myo-Electrical and Nerve Root Function Response to Focused Extracorpeal Shock Wave in Cervical Radiculopathy
Cervical Radiculopathy
Not yet recruiting
Endoscopic Posterior Cervical Foraminotomy Versus Anterior Cervical Discectomy and Fusion for Cervical Radiculopathy
Cervical Disc Herniation, Cervical Foraminal Stenosis
RecruitingObservational study
Cervical Spinal Cord Signal Abnormalities in Patients With Cervical Radicular Pain
Cervical Radiculopathy, Cervical Myelomalacia
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing TECAR therapy in people with Cervical Radiculopathy, run by Delta University for Science and Technology at 1 site in Egypt.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: opening soon, as of the sponsor's last update on 18 Dec 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact ibrahim A abu ella, Phd (+201008442281, ibrahimneuron@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
proprioception function (time frame: Baseline). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT07289607, which also lists 1 linked publication.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 18 Dec 2025.